LONDON: British regulators on Thursday approved a GlaxoSmithKline drug to treat those at high risk of developing severe COVID-19 symptoms, with the manufacturer saying it appears effective against the new Omicron variant. The antibody treatment, sotrovimab, “was found to be safe and effective at reducing the risk of hospitalisation and death in people with mild […]
from Daily Times https://ift.tt/3ohp9Ze
Subscribe to:
Post Comments (Atom)
-
from Pakistani Talk Shows, Latest Pakistan News, Urdu News, Breaking News Pakistan http://bit.ly/2SE0NXv
-
Dailymotion from Pakistani Talk Shows, Latest Pakistan News, Urdu News, Breaking News Pakistan https://ift.tt/2SsPZe5
-
In Haiti, virus crisis leaves cancer patients in limbo In early March, 31-year-old Melchior visited a doctor in his home country of Haiti, ...
No comments:
Post a Comment